As Waymo expands overseas, it remains a niche cash-burning business
Waymo is expanding internationally as Alphabet’s robotaxi unit, but remains a niche business generating just 0.3% of parent company revenue while posting widening losses.
Eli Lilly blows past estimates, hikes sales outlook on resilient Zepbound and Mounjaro demand
Eli Lilly raised its full-year revenue outlook to $91-$92 billion, citing strong demand for obesity and diabetes drugs Zepbound and Mounjaro, though its new pill Foundayo underperformed expectations.
Merck tops quarterly estimates, hikes profit outlook as new Keytruda form shows strength
Merck exceeded third-quarter expectations and raised its profit guidance, driven by stronger-than-anticipated sales of immunotherapy Keytruda and its newer injectable form Keytruda Qlex.
Restaurant Brands reports mixed results as Burger King’s U.S. turnaround shows signs of success
Restaurant Brands International reported mixed quarterly results as Burger King’s U.S. turnaround accelerated with 8.4% same-store sales growth, while Popeyes declined 2.2%.
HSBC shares slump on revenue miss, lender announces share buyback of up to $1 billion
HSBC announced a $1 billion share buyback and reported third-quarter pretax profit meeting expectations, though shares fell 6.5% on a revenue miss.
Samsung Electronics shares slid despite record profit in the third-quarter
Samsung Electronics shares fell 4.13% despite posting record third-quarter operating profit of over 100 trillion won, marking its fourth consecutive quarter of record results.